hero section gradient
15 handpicked stocks

Wartime Money

This carefully selected group of stocks focuses on the companies building modern defense systems, from aircraft to cybersecurity. These stocks are handpicked by our professional analysts based on their stable government contracts and potential to perform well during periods of global tension.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Market capitalisation breakdown for the 'Wartime Money' basket, showing total market cap and constituent market caps.

Key Takeaways for Investors:
  • Large-cap dominance suggests lower volatility and closer market tracking; performance likely leans toward stability.
  • Best used as a core, long-term holding within a diversified portfolio, not as a speculative trade.
  • Expect steady, long-term value rather than rapid, short-term gains; growth is likely gradual.
Total Market Cap
  • LMT: $113.27B

  • NOC: $85.54B

  • RTX: $232.01B

  • Other

About This Group of Stocks

1

Our Expert Thinking

These companies benefit from consistent government spending on national security, which tends to remain stable or increase during uncertain times. Defense and security contracts often span many years, providing predictable revenue streams that can weather economic downturns.

2

What You Need to Know

This group includes both established defense contractors with long-term government relationships and innovative specialists in emerging areas like cybersecurity and unmanned systems. Global tensions and expanding defense budgets worldwide serve as ongoing catalysts for growth.

3

Why These Stocks

We've selected industry leaders with significant government contracts, technological advantages, and strategic positioning in critical defense sectors. These companies provide essential national security tools and may offer portfolio diversification as they often move independently of broader market trends.

Why You'll Want to Watch These Stocks

🛡️

Recession-Resistant Revenue

Defense contractors often thrive on long-term government contracts that continue regardless of economic conditions, potentially offering stability when other sectors struggle.

🌍

Global Tensions = Growth Catalyst

Rising international conflicts and security concerns are driving increased defense spending worldwide, creating a strong tailwind for companies in this group.

🔐

The Digital Battlefield Edge

Cybersecurity and digital defense stocks in this group are positioned at the frontier of modern warfare, where nations are rapidly expanding budgets to combat evolving threats.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions